AP – COVID-19 vaccines and tests for the virus continue to boost CVS Health and the health care giant raised its annual forecast after a strong first quarter. The drugstore chain and pharmacy benefit manager said yesterday it now expects earnings of USD8.20 to USD8.40 per share for 2022. The new range mostly eclipses Wall
